Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-27 @ 11:50 PM
Study NCT ID:
NCT05042934
Status:
WITHDRAWN
Last Update Posted:
2022-02-10
First Post:
2021-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-07
First Submit QC Date:
None
Study First Post Date:
2021-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-01
Last Update Post Date:
2022-02-10
Last Update Post Date Type:
ACTUAL